ICM

About:

ICM develops a gene theraphy aimed to combat osteoarthritis and age-related mascular disease.

Top Investors: Stonebridge Capital

Description:

Total Funding Amount:

2B KRW

Headquarters Location:

California, Maryland, United States

Founded Date:

1954-01-01

Founders:

Number of Employees:

501-1000

Last Funding Date:

2017-06-28

IPO Status:

Private

Industries: